This is where we run once again into RVX's balance sheet problem. Ideally, it should be a long large trial encompassing all the details you mention.  However, now they are hostage to whatever their funding partner wants. 

That is why I think the best outcome should be a buyout of RVX so that whoever buys them, can do a Rolls Royce set of trials and bang out several indications from RVX208.  Unless of course the BP scientists do not agree with this board's optimistic take on RVX.  Or the virus has put everything into a deep freeze for now.